Sylvia Diaz is an Endocrinology/Metabolic physician affiliated with Shirley Ryan AbilityLab. OpenAlex indexes 6 publications with 511 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
323 Sunny Isles Blvd
Sunny Isles Beach, FL 33160
Telephone
786-274-8105Provider last certified this registry record 19 Dec 2025.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20253 payments
- BETA BIONICS, INC.Program year20252 payments
- Dexcom, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
66%Insulin Analog26.5%Tresiba Flextouch U-20018%Lantus Solostar14%Novolog Flexpen14%Insulin Lispro Kwikpen U-1009%Toujeo Solostar8%Novolog6%Toujeo Max Solostar6%Tresiba Flextouch U-1005%Basaglar Kwikpen U-1005%Humalog Kwikpen U-1005%Fiasp Flextouch4%Humalog Kwikpen U-2004%Lyumjev Kwikpen U-1002%Part D<11 patientsGLP-1 receptor agonist18.9%Ozempic37%Trulicity32%Mounjaro28%Rybelsus3%Part D<11 patients+ 5 more classes in this area
Hormonal (systemic)
24.1%l-Thyroxine19.2%Levothyroxine Sodium86%Synthroid14%Part D≥113 patientsThyroid Hormone Synthesis Inhibitor3.4%Methimazole100%Part D≥24 patients+ 2 more classes in this area
Cardiovascular
8.4%Statin4.6%Atorvastatin Calcium52%Rosuvastatin Calcium48%Part D≥21 patientsCholesterol absorption inhibitor1.2%Ezetimibe100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impairment and disability: Their relation during stroke rehabilitation
Archives of Physical Medicine and Rehabilitation
1998 - Stroke rehabilitation: Clinical predictors of resource utilization
Archives of Physical Medicine and Rehabilitation
1998 - Medical and neurological predictors of resource utilization in stroke rehabilitation
Journal of Stroke and Cerebrovascular Diseases
1997
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”